Jonas Busch

Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer

J. Beyer, Peter Albers, Renske Altena et al. · Annals of Oncology · 2012 · 322 citations · Full text

Medicine, Oncology, Cancer Survivorship Care +10

Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Thomas Powles, Piotr Tomczak, Se Hoon Park et al. · The Lancet Oncology · 2022 · 278 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Inhibiting WNT and NOTCH in renal cancer stem cells and the implications for human patients

Annika Fendler, Daniel Bauer, Jonas Busch et al. · Nature Communications · 2020 · 199 citations · Full text

Medicine, Cell Biology, Oncology +17

Single-cell transcriptomics reveals common epithelial response patterns in human acute kidney injury

Christian Hinze, Christine Kocks, Janna Leiz et al. · Genome Medicine · 2022 · 118 citations · Full text

Life Sciences, Cell Biology, Pathobiology +15

Piwi-interacting RNAs as novel prognostic markers in clear cell renal cell carcinomas

Jonas Busch, Monika Jung, Zofia Wotschofsky et al. · Journal of Experimental & Clinical Cancer Research · 2015 · 110 citations · Full text

Medicine, Molecular Biology, Oncology +17